Page 21 - JSOM Fall 2021
P. 21

24.  Meyers PH, Smith SW. Acute coronary syndromes. In: Mattu A,   33.  Burns E, Buttner R. Right ventricular infarction. 2021. https://
                 Swadron S, eds. CorePendium. Burbank, CA: CorePendium, LLC.   litfl.com/right-ventricular-infarction-ecg-library/. Accessed May
                 https://www.emrap.org/corependium/chapter/rec8tYnfjz2Fpd   2021.
                 GrE/Acute-Coronary-Syndromes. Updated April 23, 2021. Ac-  34.  Meine TJ, Roe MT, Chen AY, et al. Association of intravenous
                 cessed May 18, 2021.                               morphine use and outcomes in acute coronary syndromes: results
              25.  Goldberger AL. Electrocardiographic diagnosis of myocardial   from the CRUSADE Quality Improvement Initiative. Am Heart J.
                 infarction in the presence of bundle branch block or a paced   2005;149:1043–1049.
                 rhythm. Updated 13 Oct 2020.  https://www.uptodate.com   35.  Kontos MC, Diercks DB, Ho PM, et al. Treatment and out-
                 /contents/electrocardiographic-diagnosis-of-myocardial   comes in patients with myocardial infarction treated with acute
                 -infarction-in-the-presence-of-bundle-branch-block-or-a-paced   β-blocker therapy: results from the American College of Cardiol-
                 -rhythm. Accessed May 2021.                        ogy’s NCDR( ). Am Heart J. 2011;161:864–870.
                                                                             ®
              26.  Smith SW, Dodd KW, Henry TD, et al. Diagnosis of ST-elevation   36.  Rao SV, Jollis JG, Harrington RA, et al. Relationship of blood
                 myocardial infarction in the presence of left bundle branch block   transfusion and clinical outcomes in patients with acute coronary
                 with  the ST-elevation  to S-wave  ratio  in a  modified  Sgarbossa   syndromes. JAMA. 2004;292:1555–1562.
                 rule. Ann Emerg Med. 2012;60:766–776.           37.  Aronson D, Dann EJ, Bonstein L, et al. Impact of red blood cell
              27.  Burns E, Buttner R. De Winter T wave. 27 Apr 2021. https://litfl   transfusion on clinical outcomes in patients with acute myocar-
                 .com/de-winter-t-wave-ecg-library/. Accessed May 2021.  dial infarction. Am J Cardiol. 2008;102(2):115–119.
              28.  Burns E, Buttner R. ST elevation in aVR. 05 Apr 2021 https://litfl   38.  Dastur CK, Yu W. Current management of spontaneous intrace-
                 .com/lmca-occlusion-st-elevation-in-avr/. Accessed May 2021.  rebral haemorrhage. Stroke Vasc Neurol. 2017;2:21–29.
              29.  Zarama V, Adams CD, Vesga CE. A patient with chest pain and   39.  van Diepen S, Katz JN, Albert NM, et al. Contemporary manage-
                 hyperacute T waves. Chest. 2018;154:e161–e164.     ment of cardiogenic shock: a scientific statement from the Ameri-
              30.  Cadogan M. Wellen syndrome. 2021.  https://litfl.com/wellens   can Heart Association. Circulation. 2017;136:e232–e68.
                 -syndrome-ecg-library/                          40.  Burns E. Accelerated Idioventricular Rhythm (AIVR). 04 Feb
              31.  Burns E. Posterior myocardial infarction. 04 Feb 2021.   2021.   https://litfl.com/accelerated-idioventricular-rhythm-aivr/
                 https://litfl.com/posterior-myocardial-infarction-ecg-library/. Ac-  Accessed May 2021.
                 cessed May 2021.                                41.  Page RL 2nd, O’Bryant CL, Cheng D, et al. Drugs that may cause
              32.  Winter J. Posterior ECG lead placement. 2016. https://ecg-edu-  or exacerbate heart failure: a scientific statement from the Ameri-
                 cator.blogspot.com/2016/02/posterior-ecg-lead-placement.html.   can Heart Association. Circulation. 2016;134:e32–69.
                 Accessed May 2021.













                                                       APPENDIX A:
                    FIBRINOLYTICS ABSOLUTE AND RELATIVE CONTRAINDICATIONS IN STEMI

              The following table provides the absolute and relative contraindications health factors in regard to administering fibrinolytics
              in STEMI.

              TABLE A-1  Absolute and Relative Contraindications
                                    Absolute                                         Relative
              Any prior intracranial hemorrhage                 History of chronic, severe, poorly controlled hypertension
              Known structural cerebral vascular lesion (e.g., arteriovenous   Significant hypertension on presentation (SBP >180mmHg or
              malformation)                                     DBP >110mmHg)
              Known malignant intracranial neoplasm (primary or metastatic)  History of prior ischemic stroke >3 months
              Ischemic stroke within 3 months (EXCEPT acute ischemic stroke   Dementia
              within 4.5 hours)
              Suspected aortic dissection                       Known intracranial pathology not covered in absolute
                                                                contraindications
              Active bleeding or bleeding diathesis (excluding menses)  Traumatic or prolonged
                                                                (>10 minutes) CPR
              Significant closed-head or facial trauma within 3 months  Major surgery (< 3 weeks)
              Intracranial or intraspinal surgery within 2 months  Recent (within 2 to 4 weeks) internal bleeding
              Severe uncontrolled hypertension (unresponsive to emergency therapy) Noncompressible vascular punctures
              For streptokinase, prior treatment within the previous 6 months  Pregnancy
                                                                Active peptic ulcer
                                                                Oral anticoagulant therapy
              Source: O’Gara PT, Kushner FG, Ascheim DD, et al. The American College of Cardiology Foundation/American Heart Association guideline
              for the management of ST-elevation myocardial infarction: executive summary. Circulation. 2013;127:529–555 https://www.ahajournals.org/
              doi/10.1161/CIR.0b013e3182742c84 Accessed May 2021.


                                                                                  Acute Coronary Syndrome Guidelines  |  19
   16   17   18   19   20   21   22   23   24   25   26